Clinical Trials Logo

Status Asthmaticus clinical trials

View clinical trials related to Status Asthmaticus.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06171932 Enrolling by invitation - Asthma Acute Clinical Trials

Comparison Of Efficacy Of Hydrocortisone And Methyl Prednisolone In Acute Severe Asthma

Start date: November 26, 2023
Phase:
Study type: Observational [Patient Registry]

COMPARISON OF EFFICACY OF HYDROCORTISONE AND METHYLPREDNISOLONE IN ACUTE SEVERE ASTHMA In this study Investigator will compare the efficacy of hydrocortisone and methyl prednisolone in acute severe asthma that will lead to final result and beneficial effects that will help in early resoloution of symptoms and help in preventing recurrence

NCT ID: NCT00750568 Enrolling by invitation - Status Asthmaticus Clinical Trials

Intravenous Terbutaline in Severe Status Asthmaticus

Start date: October 2007
Phase: N/A
Study type: Observational

Terbutaline is a medication that is used to treat serious asthma attacks (status asthmaticus). The purpose of this study is to determine if terbutaline is effective and safe when given as a continuous intravenous infusion to children ages 2 years to 18 years of age. Children participating in this study are inpatients in the Intensive Care Unit with a diagnosis of status asthmaticus and are receiving terbutaline as part of their routine care. Blood samples and physiological assessments will be used to determine how the body is using terbutaline and how well it is working.